Item has been added

Skip to content

Same Day Dispatch via Australia Post

Get in touch with us

What Did an 815-Person Review Find About Foot-Drop Treatment After Stroke?

What Did an 815-Person Review Find About Foot-Drop Treatment After Stroke?

Quick Overview

Scientists in England reviewed five randomised trials of 815 adults after stroke. They compared FES, a walking form of EMS, with ankle braces for foot-drop.

They timed the 10-metre walk, distance walked, timed up-and-go, and mobility scores. Checks ran from six weeks to twelve months. Both groups walked faster and farther than at the start. Step counts also rose with regular use.

The paper ran in the peer-reviewed Journal of Rehabilitation Medicine. Authors were from Huddersfield and Salford. The numbers suggest supported walking with EMS can help after stroke. Read the full post for the tests, figures, and limits.


We always provide direct links to the original research at the end of every article so you can review the evidence yourself.

 

 

Stroke Walking Study: Electrical Stimulation Helped Hundreds Move With More Confidence

A large research review asked a simple question.
Can electrical stimulation help people walk after stroke?
The answer from the data was encouraging.

 

 

Foot-drop is common after stroke.
The toes catch.
Steps slow down.
Walking can feel unsafe.

 

 

Clinicians often use a brace called an ankle-foot orthosis.
Some also use functional electrical stimulation, or FES.
Many people know this family of tools as EMS.

FES sends timed pulses to the nerve that lifts the foot.
The pulse is meant to help the foot clear the ground.
This review compared that approach with a standard brace.

Who ran the study

 

 

The paper was led by Sarah Prenton.
She worked at the University of Huddersfield in England.
Co-authors were Kristen Hollands and Laurence Kenney.
They worked at the University of Salford.

Both are established United Kingdom universities.
The team used a public review protocol.
They followed PRISMA reporting rules.
They used the Cochrane risk-of-bias tool.

 

 

The paper appeared in 2016 in the Journal of Rehabilitation Medicine.
That journal is peer-reviewed and indexed in MEDLINE.
It is owned by a Swedish non-profit foundation started in 1969.
Sweden has a long record in rehabilitation science.

This blog is reporting that published paper.
It is not selling a device.
It is not medical advice.

What the researchers did

 

 

They searched nine major databases.
They kept only English-language randomised controlled trials.
Seven papers met the rules.
Some papers came from the same trials.
That left five trials and 815 stroke adults.

Every participant was over 18.
Time since stroke ranged from weeks to almost seven years.
Some people already used a brace.
Others were new to both options.

Trials lasted from six weeks to twelve months.
People used the devices at home in several studies.
Some also had physiotherapy.

What they measured

 

 

The team looked at walking, not slogans.
The main tests were practical.

They measured 10-metre walking speed.
They measured how far people could walk in a set time.
They measured the timed up-and-go test.
They measured perceived mobility on the Stroke Impact Scale.

They also checked overlapping time points.
Those windows were about 4 to 6 weeks.
Then 12 to 13 weeks.
Then 26 to 30 weeks.

What the numbers showed

 

 

Both groups improved.
That is the bright finding.

Final 10-metre walk data covered 789 people.
The pooled difference between FES and braces was tiny.
Mean difference was 0.01 m/s.
The p-value was 0.79.

 

 

So the two aids were statistically similar at the last check.
Both sides of the comparison had moved forward from baseline.

Walking endurance was pooled for 761 people.
The standardised mean difference was -0.07.
The p-value was 0.31.
Again, the groups looked comparable.

 

 

Two trials used the timed up-and-go test.
Authors reported similar gains.
P-values were 0.812 and 0.539.

Perceived mobility used the Stroke Impact Scale.
That analysis included 701 people.
The mean difference was 0.31 points.
The p-value was 0.80.

In short, people using FES walked better than they had at the start.
People using braces did too.

Signs of real-world practice

 

 

One large trial counted daily steps.
After weeks of use, step counts rose in both groups.
In the FES arm, average steps moved from about 2,092 to 2,369.
That was from week 6 to week 30.

More safe steps means more walking practice.
The authors said task practice may help explain the gains.
Used during walking, FES can support that practice.

 

 

One smaller trial looked at gait details.
It reported some timing and kinematic differences favouring FES.
Those measures were not pooled across all five trials.

What this does not prove

 

 

The review did not show FES beating braces on the main walking tests.
The authors said that clearly.
Many people expected FES to win.
The pooled activity scores were even.

The trials only included adults after stroke.
Results should not be stretched to every diagnosis.
Device setup details were often thin.
Assessor blinding was a common weak point.

This is evidence about walking aids.
It is not a promise of recovery.
It is not a cure claim.

Why the paper still matters

 

 

Foot-drop can shrink a person’s world.
These trials measured speed, distance, sit-to-stand walking, and confidence.
Across 815 people, FES users improved on those measures.

The stimulation was used as a walking aid.
Several protocols encouraged regular daytime use.
The pattern fits a simple idea.
More supported walking practice can add up.

FES is a clinical tool.
A trained clinician should assess nerve response, skin, and gait.
A brace may still be the better fit for some people.
The review supports informed choice, not a sales pitch.

Source

Prenton S, Hollands KL, Kenney LPJ.
Functional electrical stimulation versus ankle foot orthoses for foot-drop: a meta-analysis of orthotic effects.
Journal of Rehabilitation Medicine. 2016;48:646–656.
doi: 10.2340/16501977-2136.

Talk with a doctor or physiotherapist before trying any stimulation device.
Individual results vary.
This article reports published research.
It does not advertise a product.

Featured Product

 



 

ORIEMS FIT ULTIMATE KIT 💪 is a 100% Australian award-winning product.

Voted YEAR’S BEST ⭐ for 2024 and 2025.

It is a wide-range targeted muscle stimulator enhanced with EMS technology, designed to support your fitness and relaxation routine. 🌟

Trusted by more than 10,000 happy users with over 450 five-star Google reviews. 😊

Check availability.

Product Disclaimer:

This product is designed only to support fitness and relaxation routines. It is not a medical device and has not been evaluated or registered by the TGA. It is not intended to diagnose, treat, cure or prevent any disease or medical condition. It may not be suitable for everyone. Please consult your doctor or healthcare practitioner before using it.


Like this Research Digest? 📚


Share it with your friends 💬👇 https://bit.ly/3VrGuBO

About Our Health Research Digest

We bring you the latest and most important health research papers — simplified and easy to understand.

Each study is broken down into clear, concise summaries and engaging podcasts, with direct links to the original research so you can explore further whenever you like.

We also create content based on your requests. If you’re curious about a specific health topic or would like us to find relevant studies, simplify the findings, and turn them into a podcast, just let us know.

Don’t hesitate to reach out — we’re here to help make health research accessible and useful for you. Contact us anytime.

 

More  EMS   Research Scientists Are Studying

1. Can  EMS   reduce fat? 

2. Can   EMS  increase calorie burn while sitting?

3. Can   EMS  support muscle toning and muscle gains?

4. Can   EMS   improve athletic  training?

5. Can   EMS   play a role in muscle loss & frailty?

6. Can   EMS  reduce pain? 

7.   EMS   vs TENS: What are the differences?

8. Can  EMS  play a role after stroke?


Research Summary



Detail What the paper reports
Full title Functional electrical stimulation versus ankle foot orthoses for foot-drop: a meta-analysis of orthotic effects
Study type Systematic review and meta-analysis of randomised controlled trials, reported using PRISMA
Purpose Compare combined-orthotic walking effects of FES (a walking form of EMS) with ankle-foot orthoses after a period of use
Authors Sarah Prenton, Kristen L. Hollands, Laurence P. J. Kenney
Research centres University of Huddersfield and University of Salford, United Kingdom
Journal Journal of Rehabilitation Medicine, volume 48, pages 646–656, 2016
Publisher Foundation of Rehabilitation Information / Medical Journals Sweden AB, Sweden
Identifiers DOI 10.2340/16501977-2136; PMID 27563700; accepted 15 July 2016
Original study links Journal page · DOI · PubMed
Search sources MEDLINE, AMED, CINAHL, CENTRAL, Scopus, REHABDATA, PEDro, NIHR CRD, clinicaltrials.gov, plus citation searches
Evidence pool 7 eligible RCTs grouped into 5 synthesised trials; 815 adults after stroke
Who was studied Adults over 18 with stroke-related foot-drop; time since stroke from 51.7 days to about 6.9 years
What was compared Common-peroneal FES during walking versus AFO; surface systems in most trials, one implanted system
How progress was measured 10 m walk speed, walking distance/endurance, timed up-and-go, Stroke Impact Scale mobility, plus some gait and activity-monitor data
Time points Final assessment plus overlapping windows at 4–6 weeks, 12–13 weeks, and 26–30 weeks; one trial followed people to 12 months
Key walking-speed result Final 10 m walk pooled from 789 people: mean difference 0.01 m/s, p = 0.79, showing comparable improvement
Other pooled results Endurance in 761 people, p = 0.31; timed up-and-go p = 0.812 and 0.539; SIS mobility in 701 people, p = 0.80
Extra practice signal One large trial found daily steps rose with use; FES-group averages moved from about 2,092 to 2,369 steps
Main conclusion FES and AFOs both showed positive combined-orthotic effects on key walking measures after stroke; effects were statistically similar
Limits noted by authors Stroke-only sample, mixed device details, some bias risk, and a need for longer high-quality trials

 

 

Disclaimer

This article is published for general information and educational purposes only. It does not constitute medical advice, health advice, diagnosis, or treatment of any kind.

All content on this website, including any studies, research, or information mentioned, is provided for informational purposes only and does not imply or guarantee any specific health outcomes.

We are not affiliated with, endorsed by, or connected in any way to any researchers, universities, research centres, journals, or institutions referenced in any article. No reference to any study, researcher, or publication should be interpreted as an endorsement or recommendation of any products sold or featured on this website.

Our products (and any products featured or linked in this article) are not intended to diagnose, treat, cure, prevent, or manage any disease or medical condition. Individual results may vary significantly. No guarantees or warranties are made regarding effectiveness, safety, or specific outcomes.

Always consult a qualified healthcare professional before using any product mentioned on this website or making any changes to your health routine, especially if you have a pre-existing medical condition, are pregnant, breastfeeding, have a pacemaker, or are taking medication.

To the fullest extent permitted by law, ORIEMS FIT, its directors, employees, authors, affiliates, and agents disclaim all liability for any loss, damage, cost, expense, or injury (whether direct, indirect, consequential, special, or incidental) arising from the use of, or reliance upon, any information in this article or from the purchase or use of any products featured or sold on this website.

© [ORIEMS FIT] – All Rights Reserved.

Leave a comment

Please note, comments must be approved before they are published